Geron could resume stem cell trial
Geron Corp., a Menlo Park-based stem cell research company, has moved closer to a federal approval that would allow it to resume its testing of an embryonic stem cell therapy for spinal cord injuries. While the U.S. Food and Drug Administration …
[Read the full article here]Related News:
Clinical Trial Is First To Use A Human Neural Stem Cell Line To Deliver An Anticancer …
FDA approves Neuralstem's IND for commencing a stem cell trial to treat Amyotrophic Lateral Sclerosis
FDA approves first human neural stem cell clinical trial to treat brain tumors